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bstract
The present study, antioxidant, enzyme inhibitory, anti-inflammatory and antimicrobial activity of isolated compounds such as Decussatin
1), Gentiacaulein (2), Swertianin (3), 1,8-dihydroxy-2,6-dimethoxy xanthone (methylswertianin) (4) 8-hydroxy-1,2,4,6-tetramethoxyxanthone
5) and 1,2-dihydroxy-6-methoxyxanthone-8-O--d-xylopyranosyl (6) were investigated using an in  vitro  model. Results of antioxidant
tudies revealed that the compound 6  possessed an efficient 2,2-diphenyl-1-picryl-hydrazyl (DPPH•) (IC50 07.19 ±  4.56 mol/mL), 2,2-
zinobis (3-ethylbenzothiozoline-6-sulfonic acid) (ABTS•+) (42.62 ±  0.25 mmol/L TE/g), superoxide (57.89 ±  3.45 mol/mL), nitric oxide
18.45 ±  1.23 mol/mL) and hydroxyl (12.13 ±  2.76 mol/mL) radical scavenging activities, ferric reducing antioxidant power (14.76 ±  0.10 molar
e (II)/g), metal chelating (213.85 ±  27.18 mg EDTA/g) ability. Compounds 6  and 3  exhibited significant anti-proliferative activity. Compound 6
isplayed strongest antibacterial activity against Streptococcus  pneumoniae  and Escherichia  coli  with MIC value of 3.90 g/mL and 21.21 ±  0.25
nd 20.27 ±  0.11 mm zone of inhibition at 25 g/mL concentration respectively. In the membrane stabilization and protein denaturation test 3  was
he most potent with an IC50 value of 12.57, 18.75 mol/mL respectively.
 2015 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  Introduction
Natural compounds of plants are derived from the occur-
ence of biodiversity. Plants produce these compounds to
nhance their survival and competitiveness. Due to their
Abbreviations: DPPH, 2,2-diphenyl-1-picrylhydrazyl; DMRT, Duncan’s
ultiple Range Test; BHT, butylated hydroxytoluene; ABTS, 2,2′azinobis
3-ethylbenzothiozoline-6-sulfonic acid) diammonium salt; TPTZ, 2,4,6-
ripyridyl-S-triazine; EDTA, ethylenediamine tetraacetic acid; NMR, nuclear
agnetic resonance; MTT, 3-(4,5-dimethylthiazol)-2,5-diphenyl tetrazolium
romide; HMBC, Heteronuclear Multiple Bond Correlation; TLC, Thin layer
hromatography; ATCC, American type culture collection; MIC, minimum
nhibition concentration; CFU, colony forming unit; SEM, standard error of mea-
urement; HSQC, heteronuclear single quantum coherence; IC50, half maximal
nhibitory concentration; ANOVA, analysis of variance; TE, Trolox equivalents.
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iological activities, many plant-derived compounds are used
or the treatment of human illnesses or diseases. A World Health
rganization (WHO) survey indicated that about 70–80% of
he world’s population relies on traditional medicine based
ainly on plant materials for their primary healthcare [1]. Even
hough phenolic compounds are ubiquitous and rich in medic-
nal herbs and dietary plants, these compounds have gained
uch attention due to their antioxidant activities and use in
edical practice as anti-inflammatory, choleretic, anti-tumoral
nd other agents [2–4]. Clinical evidence has demonstrated
hat chemoprevention by plant-derived phenolic compounds
s an inexpensive, readily applicable, acceptable and accessi-
le approach to various disease control and management [5].
he unprecedented structures of these molecules make them
xcellent synthetic targets and their potent activity against a
road number of therapeutic indications makes these natural
roducts excellent drug lead candidates for new therapeutics
6].
lsevier B.V. All rights reserved.
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Swertia  corymbosa  (Griseb.) Wight ex  C.B. Clarke is a well
nown medicinal plant and all parts of this plant have been
mployed for the treatment of diarrhea, fever, jaundice, dia-
etic, inflammation and nervous disorders in Indian traditional
ystems of medicine. Medicinal value especially anti-diabetic
roperty of S.  corymbosa  is well recorded in traditional litera-
ure [7]. In Yunani system, S.  corymbosa  is used as astringent
onic, stomachic, lessens inflammation, sedative to pregnant
terus and chronic fevers [7]. Recently pharmacological stud-
es showed that its extensive biological activities such as
ntioxidant, anti-proliferative, anti-inflammatory, anti-diabetic,
nti-convulsant, sedative, anxiolytic and anti-microbial activi-
ies of the extracts [7–12]. Phytochemical studies revealed the
resence of alkaloid, flavonoids, phenols, xanthones which rep-
esented the main active components in S.  corymbosa  aerial parts
7]. Our recently published study showed that the xanthones
n S.  corymbosa  display anti-inflammatory anti-nociceptive and
nti-diabetic activities, but there has been very little infor-
ation on antioxidant and medicinal properties of isolated
anthones from S.  corymbosa. Hence, the present study attempts
o investigate the antioxidant, anti-proliferative, anti-microbial,
nti-inflammatoryand type II diabetic related enzyme inhibition
roperties of the isolated compounds using in  vitro  methods.
.  Materials  and  methods
.1.  Chemicals  and  reagents
All the antioxidant, anti-diabetic, antimicrobial chemicals
nd standards were obtained from Hi-media (Mumbai, India)
nd Sigma–Aldrich (St. Louis, MO, USA). Petroleum ether,
hloroform, ethyl acetate and all the culture media were pur-
hase from Hi-media. All other reagents used were of analytical
rade.
.2.  Plant  material  and  isolation
The aerial parts of S.  corymbosa  were collected from
ellingiri hills. The plantmaterial was authenticated by Dr. R.
amachandran, Professor, Department of Botany, Bharathiar
niversity, Coimbatore. Vouchers Specimen (No: 006144) of
he plant material is deposited at the Department herbarium cen-
er, Department of Botany, Bharathiar University. The extraction
nd isolation of 1-hydroxy-3,7,8-trimethoxyxanthone (1), 1,7-
ihydroxy-3,8-dimethoxyxanthone (2) and 1,2,8-trihydroxy-6
ethoxy xanthone (3), 1,8-dihydroxy-2,6-dimethoxyxanthone
4), 8-hydroxy-1,2,4,6-tetramethoxyxanthone (5) and 1,2-
ihydroxy-6-methoxyxanthone-8-O--d-xylopyranosyl (6)
rom S.  corymbosa  was performed as described in our previous
tudy [8].
.3.  Antioxidant  activity
•.3.1.  Radical  scavenging  activity  using  DPPH method
The antioxidant activity of the compounds was determined
n terms of hydrogen donating or radical scavenging ability,
sing the stable radical 2,2-diphenyl-2-picrylhydrazyl (DPPH•),
p
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ccording to the method of Blois [13]. A methanol solution of
he sample compounds at various concentrations was added to
 mL of 0.1 mmol/L methanolic solution of DPPH• and allowed
o stand for 20 min at 27 ◦C. The absorbance of the sample was
easured at 517 nm. Methanol was served as blank and solu-
ion without compounds served as control. The percentage of
ree radical scavenging capacity of the compound was calcu-
ated and expressed as IC50 value. BHT and BHA were used as
 standard antioxidant.
.3.2.  ABTS  radical  scavenging  activity
The total antioxidant activity of the samples was measured by
BTS (2,2′-azinobis (3-ethylbenzothiozoline)-6-sulfonic acid)
adical cation decolourization assay according to the method
f Re et al. [14]. ABTS•+ was produced by reacting 7 mmol/L
BTS aqueous solution with 2.4 mmol/L potassium persulfate
n the dark for 12–16 h at room temperature. Prior to assay, this
olution was diluted in ethanol (about 1:89, v/v) and equilibrated
t 30 ◦C to give an absorbance of 0.700 ±  0.02 at 734 nm. The
tock solution of the sample compounds were diluted such that
fter introduction of 10 L aliquots into the assay, they pro-
uced between 20 and 80% inhibition of the blank absorbance.
fter the addition of 1 mL of diluted ABTS solution to 10 L of
ample or Trolox (final concentration 0–15 mol/L) in ethanol,
bsorbance was measured at 30 ◦C exactly 30 min after the initial
ixing. Triplicate determinations were made at each dilution of
he standard and the percentage inhibition was calculated against
he blank (ethanol) absorbance at 734 nm and then was plotted as
 function of Trolox concentration. The unit of total antioxidant
ctivity (TAA) is defined as the concentration of Trolox hav-
ng equivalent antioxidant activity expressed as mM/g sample
ompound.
.3.3. Superoxide  radical  (O2•−)  scavenging  activity
The ability to inhibit formazan formation by scavenging
uperoxide radicals by the compounds was studied by the
ethod of Beauchamp and Fridovich [15]. Each 3 mL reaction
ixture (50 mmol/L sodium phosphate buffer (pH 7.6), 20 g
iboflavin and 12 mmol/L EDTA and 0.1 mg NBT) with com-
ounds in each test tube was illuminated for 90 s. Illuminated
eaction mixture served as negative control, while the mixture
ithout compounds in dark was taken as blank. Immediately
fter illumination, the absorbance was measured at 590 nm.
he activity was compared to BHT and BHA. The percentage
nhibition of superoxide anion generation was calculated and
xpressed as IC50 values.
.3.4.  Nitric  oxide  scavenging  activity
The assay is based on the principle that sodium nitroprusside
n aqueous solution at neutral pH spontaneously generates nitric
xide, which in turn reacts with oxygen to produce nitrite ions
hat can be estimated using Greiss reagent. Scavengers of nitric
xide compete with oxygen molecules that result in reduced
roduction of nitrite ions. In the experiment, sodium nitroprus-
ide (10 mmol/L) in phosphate buffered saline was mixed with
ifferent concentrations of samples/standard followed by incu-
ation at room temperature for 150 min. The same reaction
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ixture without the sample/standard served as the control. After
he incubation period, 0.5 mL of Griess reagent (1% sulfanil-
mide, 2% H3PO4 and 0.1% N-(1-naphthyl) ethylenediamine
Cl) was added and the absorbance of the formed chromophore
y the diazotization of nitrite with sulphanilamide and subse-
uent coupling with naphthylethylene-diamine dihydrochloride
s measured spectrophotometrically at 546 nm [16]. The percent
cavenging activity of the nitric oxide generated was measured
y comparing the absorbance values of control and test prepa-
ations and the results were expressed in terms of IC50 values.
HA was used as a reference standard.
.3.5. Ferric  reducing  antioxidant  power  (FRAP)  assay
The antioxidant capacities of different compounds of sam-
les were estimated according to the procedure described by
ulido et al. [17]. FRAP reagent (900 L), prepared freshly and
ncubated at 37 ◦C, was mixed with 90 L of distilled water
nd 30 L of test sample or methanol (for the reagent blank).
he test samples and reagent blank were incubated at 37 ◦C for
0 min in a water bath. The final dilution of the test sample in
he reaction mixture was 1/34. The FRAP reagent was prepared
y mixing 2.5 mL of 20 mmol/L TPTZ (2,4,6-tripyridyl-s-
riazine) in 40 mmol/L HCl (Hydrochloric acid), 2.5 mL of
0 mmol/L FeCl3·6H2O and 25 mL of 0.3 M Acetate buffer (pH
.6). At the end of incubation, the absorbance readings were
aken immediately at 593 nm against the reagent blank using a
pectrophotometer. Methanolic solutions of known Fe (II) con-
entration, ranging from 100 to 2000 mol/L (FeSO4·7H2O)
ere used for the preparation of the calibration curve. The
arameter equivalent concentration was defined as the concen-
ration of antioxidant having a ferric-TPTZ reducing ability
quivalent to that of 1 mmol/L FeSO4·7H2O. Equivalent con-
entration was calculated as the concentration of antioxidant
iving an absorbance increase in the FRAP assay equivalent to
he theoretical absorbance value of 1 mol/L concentration of Fe
II) solution.
.3.6.  Metal  ion  chelating  activity
The chelating activity of compounds was determined by the
ethod of Dinis et al. [18]. 800 L of samples were added to
00 L solution of 2 mmol/L FeCl2. The reaction was initiated
y the addition of 400 L of 5 mmol/L ferrozine and incubated
t room temperature for 10 min. Absorbance of the sample was
hen measured spectrophotometrically at 562 nm against the
ater (blank). The metal chelating capacities of the compounds
ere expressed as mg EDTA equivalents/g compound.
.3.7. The  inhibition  of  lipid  peroxidation
A modified TBA reactive species assay by Banerjee et al.
19] was used to measure the lipid peroxide formed, using
gg-yolk homogenates as lipid-rich media Ruberto et al. [20].
alondialdehyde, a secondary product of the oxidation of
olyunsaturated fatty acids, reacts with two molecules of TBA,
ielding a pinkish red chromogen with an absorbance maximum
t 532 nm. Egg homogenate (0.5 mL 10% in distilled water, v/v)
nd different concentrations of the test solution was mixed in a
est tube and the volume was made up to 1 mL by adding distilled
m
a
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ater. Finally, 0.05 mL FeSO4 (0.07 mol/L) was added to the
bove mixture and incubated for 30 min, to induce lipid peroxi-
ation. Thereafter, 1.5 mL of 20% acetic acid (pH adjusted to 3.5
ith NaOH) and 1.5 mL of 0.8% TBA (w/v) (prepared in 1.1%
DS) and 0.05 mL 20% TCA were added, vortexed and then
eated in boiling water bath for 60 min. After cooling, 5.0 mL
f 1-butanol was added to each tube and centrifuged at 3000 r
er minute for 10 min. The absorbance of the organic upper layer
as measured at 532 nm:
Inhibition =  100% × (A0 −  As)/A0
here A0 is the absorbance of the control, and As is the
bsorbance of the tested sample.
.3.8. Hydroxyl  radical  scavenging  activity
The scavenging activity for hydroxyl radicals was measured
ccording to the method [21] with slight modification. Reac-
ion mixture contained 0.5 mL of 7.5 mmol/L FeSO4, 0.5 mL
.5 mmol/L 1,10-phenathroline and 2.5 mL of 0.2 mol/L phos-
hate buffer (pH 7.8), 0.5 mL of 30 mmol/L H2O2 and different
oncentration of test solution. The reaction was started by
dding H2O2. After incubation at room temperature for 5 min the
bsorbance of the mixture at 536 nm was measured. Hydroxyl
adical scavenging activity (%) = 100 ×  (A  562 (control) −  A  562
sample)/A (562 control)) and expressed in IC50 value.
.4.  Anti-proliferative  activity
.4.1.  Cell  lines  and  culture
The human cervical cancercell line (HeLa) HeLa (cervical),
epatocellular carcinoma (HepG2), neuroblastoma (IMR-32)
nd NIH 3T3 mouse embryonic fibroblasts were obtained from
ational Center for Cell Science (NCCS), Pune. The cancer-
us cell lines were maintained in Dulbecco’s Modified Eagle’s
edium (Sigma Aldrich Inc., USA) supplemented with 10%
etal bovine serum (Gibco BRL., USA) in a CO2 incubator.
.4.2. MTT  assay
For screening experiment, the cells were seeded into 96 well
lates with 100 L of respective medium containing 10% FBS,
t plating density of 10,000 cells/well and incubated at 37 ◦C,
% CO2, 95% air, and 100% relative humidity for 24 h prior to
ddition of compound. The compound was solubilized in DMSO
nd diluted in the respective serum free medium. After 24 h,
00 L of the medium, containing the compound and camp-
othecin as standard at various concentrations (6.25, 12.50, 25,
0 and 100 mol/L) was added and incubated at 37 ◦C, 5% CO2,
5% air and 100% relative humidity for 48 h. Triplicate was
aintained and the medium without compound served as neg-
tive control. After incubation, 15 L of MTT (5 mg/mL) in
BS was added to each well and incubated at 37 ◦C for 4 h. The
edium with MTT was then flicked off and the formed form-
zan crystals were solubilized in 100 L of DMSO and then
he absorbance measured at 570 nm using micro plate reader
22]. The % cell inhibition was determined using the following
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ormula and graph was plotted between % cell inhibition and
oncentration as follows:
Cell viability =  test absorbance/control absorbance ×  100
IC50 (inhibition concentration) values were defined as the
oncentrations of compound required to reduce the absorbance
o 50% of the control values.
.5.  Antimicrobial  activity
.5.1.  Test  bacteria
The antibacterial activity of isolated compounds 1–6 were
valuated against 6 pathogenic bacteria such as Escherichia  coli
ATCC 25922), Pseudomonas  aeruginosa  (ATCC 27853),
taphylococcus aureus  (ATCC 29213), Streptococcus  pneumo-
iae (ATCC 33400) Klebsiella  pneumoniae  (ATCC 10031) and
acillus subtilis  (ATCC 6633) procured from the Institute of
icrobial Technology (IMTECH) Chandigarh, India. All the
trains were stored in the appropriate medium before use.
.5.2. Disc  diffusion  method
Disc diffusion method [23] was used for the evaluation of
ntibacterial activity of isolated compounds using 100 L of
uspension containing 108 CFU/mL of bacteria spread on the
noculated agar. A sterile cotton swab was dipped into the inocu-
ums suspension to remove the excess of fluid. Whatmann filter
aper discs (6 mm diameter) were prepared at the concentration
f 25 g/disc for isolated compounds and 10 g/disc reference
ntibiotic (Ciprofloxacin). A disc prepared with only the corre-
ponding volume of DMSO was used as negative control. The
etriplates were then incubated and antimicrobial activity was
valuated by measuring the diameter of the zones of inhibition
round the disc. The experiments were repeated in triplicate and
he results were expressed as average values.
.5.3.  Minimum  inhibitory  concentration
The minimum inhibitory concentration (MIC) of isolated
ompounds of S.  corymbosa  was determined using the micro-
ilution assay in 96 well micro-plates [24]. Briefly, five
undred microlitres of each resuspended sample (1.0 mg/mL)
n DMSO (2%). Serial two-fold dilutions were prepared from
he stock solution to give concentrations ranging from 500 g to
.90 g/mL of the isolated compounds for bacteria. The high-
st concentration of DMSO remaining after dilution (5%, v/v)
aused no inhibition to bacterial growth. DMSO served as neg-
tive control. Streptomycin and Ciprofloxacin were served as
ositive controls. An aliquot of 100 L standardized suspension
f the test bacteria (108 CFU/mL) was transferred to a well of 96
lates. Then, 100 L diluted samples were also added to each
ell and incubated at 37 ◦C for 24 h. The MIC was defined as
he lowest concentration of samples which inhibited the visible
rowth of tested microorganisms. For further reconfirmation,
0 L of MTT reagent (1 mg/mL) was added as an indicator
or microbial growth to each well of the microtiter plates, fol-
owed by 20 min incubation at 37 ◦C. The reagent-suspension
olor will remain clear or yellowish indicating complete inhibi-
ion activity as opposed to dark blue for growth [25]. The MIC
m
o
s
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as recorded as the most repeatable minimum concentration of
riplicate.
.6.  In  vitro  anti-inﬂammatory  activity
.6.1.  Protein  denaturation  assay
The reaction mixture consisted of 2 mL of different con-
entration (6.25, 12.50, 25, 50 and 100 mol/L) of isolated
ompounds 1–6  or standards diclofenac sodium and 2.8 mL
hosphate buffer saline (pH 6.3) was mixed with 2 mL of egg
lbumin (form fresh hen’s egg) and incubated at 37 ◦C for
5 min. Denaturation was induced by keeping the reaction mix-
ure at 70 ◦C in a water bath for 10 min. After cooling, turbidity
as measured spectrophotometrically 660 nm (Shimadzu, UV
800). For negative control 2 mL of egg albumin and 2.8 mL
hosphate buffer saline (pH 6.3) were used. Each experiment
as done in triplicate and the average was taken. The percent-
ge inhibition of protein denaturation was calculated by using
he following formula [26]:
Inhibition =  absorbance of test sample
−  absorbance of control/absorbance of control ×  100.
The compound/standard drug concentration for 50% inhibi-
ion (IC50) was determinate by plotting percentage inhibition
ith respect to control against treatment concentration.
.6.2. Membrane  stabilization  assay
The principle concentrated in this method is stabilization of
oat red blood cell membrane by hypo tonicity induced mem-
rane lyses. Blood was collected 2 mL from healthy goat and
as mixed with equal volume of sterilized Alsever’s solution
2% dextrose, 0.8% sodium citrate, 0.5% citric acid and 0.42%
aCl in distilled water) and centrifuged at 3000 r per minute.
he packed cells were washed with isosaline and a suspension in
0% (v/v). Reaction mixture (4.5 mL) contains 1 mL phosphate
uffer, 2 mL hyposaline, 1 mL of different concentration of iso-
ated compounds 1–6  (6.25, 12.50, 25 50 and 100 mol/mL) and
.5 mL RBC (Red blood cells) suspension. Diclofenac sodium
as used as the reference drug. The reaction mixture was served
s a control. The assay mixtures were incubated at 37 ◦C for
0 min and centrifuged at 3000 r per minute for 20 min and
he supernatant solution was estimated using UV analysis at
60 nm. The percent GRBC membrane stabilization activity was
alculated by the formula [27]:
 Inhibition =  Control −  Sample/Control ×  100.
.7.  In  vitro  anti-diabetic  activity
.7.1.  Inhibition  assay  for  α-glucosidase
The inhibition of -glucosidase assay is a modification of theethod previously described by Kim et al. [28]. Five microlitre
f the -glucosidase solution (10 units/mL in 0.1 mol/L potas-
ium phosphate buffer, pH 6.8) was mixed with 250 mL of
he different compounds (12.5–62.5 mol/mL) was mixed with
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20 mL of 0.1 mol/L potassium phosphate buffer (pH 6.8). After
0 min of incubation at 37 ◦C, 10 mL of p-nitrophenyl glucopy-
anoside (pNPG, 10 mmol/L) was added and the mixture was
e-incubated at 37 ◦C in a water bath for 30 min. The reaction
as terminated by the addition of 650 mL of Na2CO3 solu-
ion (1 mol/L). Aliquots (0.3 mL) were withdrawn and mixed
ith distilled water (4.7 mL). The amount of released product
p-nitrophenol) was measured at 410 nm using a UV spectropho-
ometer to estimate the enzymatic activity. The IC50 value was
efined as the concentration of the compound required to inhibit
0% of the -glucosidase activity under the assay conditions:
-Glucosidase inhibitory activity(%) =  (A  −  B)/A  ×  100
here A was the optical density of the reaction blank. The reac-
ion blank mixture contained the same volume of the buffer
olution instead of the sample; B  was the optical density of the
eaction in the presence of both -glucosidase and compound
ample.
.7.2. Inhibition  assay  for  α-amylase  activity
-Amylase inhibitory activity was assayed according to
he procedure described by Wang et al. [29] with a slight
odification. -Amylase activity was determined using solu-
le starch(1%) as a substrate in 0.05 mol/L sodium phosphate
uffer(pH 6.8) containing 1 mmol/L CaCl2. Briefly, 400 L
f -amylase solution (20 U/mL) was mixed with1.0 mL of
odium phosphate buffer (pH 6.8) and 200 L of the differ-
nt compounds (12.5–62.5 mg/mL). After incubation at 37 ◦C
or10 min, 300 L of the starch solution (1%) was added and
he mixture re-incubated at 37 ◦C for 20 min. The reaction was
erminated by adding 0.2 mL of dinitrosalicylic acid solution
nd boiled for 10 min in a boiling water bath. The total volume
as made up to 8.0 mL with distilled water. The absorbance
as measured at 540 nm against a control containing a buffer
olution in place of the enzyme solution. Acarbose was used as
 positive control. The assay was performed in triplicate. Inhi-
ition (%) was calculated using the equation for -glucosidase
ssay.
.8.  Statistical  analysis
The results were expressed as mean ±  SD and statistical anal-
sis was carried out by analysis of variance (ANOVA) followed
y Duncan’s multiple tests. P  < 0.05 was considered as indicative
f significance as compared to the control group. All calculations
ere performed using SPSS version17.0 (SPSS Inc., Chicago,
llinois, USA).
.  Results
.1.  Structures  of  isolated  compoundsThe structure of 1-hydroxy-3,7,8-trimethoxyxanthone (1),
,7-dihydroxy-3,8-dimethoxyxanthone(2) and 1,2,8-trihydro-
y-6 methoxy xanthone (3), 1,8-dihydroxy-2,6-dimethoxy-
anthone (4), 8-hydroxy-1,2,4,6-tetramethoxyxanthone (5) and
a
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r
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,2-dihydroxy-6-methoxyxanthone-8-O--D-xylopyranosyl (6)
Fig. 1A) were previously reported [8,30].
.2.  Antioxidant  capacity  of  the  compounds
The bioactive compounds 1–6  obtained from petroleum ether
nd ethyl acetate extracts of S.  corymbosa  was tested for possi-
le antioxidant activity by several complementary test systems
amely DPPH, ABTS, OH, Nitric oxide radical, Super oxide
adical scavenging activity, FRAP, metal chelating and lipid
eroxidation inhibition.
.2.1.  DPPH  radical  scavenging  activity
DPPH, a relatively stable organic radical with a characteristic
trong absorbance band at 517 nm in visible spectroscopy (deep
iolet color) is used to evaluate the free radical scavenging ability
f the investigated sample. The best known natural and synthetic
ntioxidant standards, Viz., BHA and BHT were used as positive
ontrol for comparison. DPPH• radical scavenging activity is a
easure of non-enzymatic antioxidant activity. When an antiox-
dant scavenges the DPPH• free radical by donating hydrogen,
he purple color of the DPPH solution becomes light yellow. The
ecrease in the absorbance was taken as a measure of the extent
f radical scavenging activity. A lower IC50 value corresponds
ith the higher antioxidant power.
In the present study, all the samples were able to
nteract intensively with DPPH and reduced the stable vio-
et DPPH radical to the yellow DPPH-H, reaching their
0% reductive plateau ranging between 07.19 ±  4.56 and
1.12 ±  3.54 mol/mL for compounds 1–6. The reference
ntioxidant BHA recorded the highest scavenging efficiency
oward DPPH radicals (25.58 ±  1.65 mol/mL), followed by
HT (30.56 ±  2.90 mol/mL). Among the isolated compounds
1–6) examined, the compound 3  (11.37 ±  3.76 mol/mL) and
ompound 6 (07.19 ±  4.56 mol/mL) possessed effective DPPH
adical quenching capacity with their IC50 value less than
2 mol/mL. Interestingly, these values were significantly lower
P < 0.05) that the standard antioxidants tested (Table 1) indicat-
ng their superior radical scavenging potential.
.2.2.  ABTS•+ Scavenging  activity
The Trolox equivalent antioxidant capacity (TEAC) was
easured using the improved ABTS radical cation decoloriza-
ion assay. The decolorization of the ABTS cation radical is
n anabiguous way to measure the TEAC of the test drugs.
ince, TEAC is a measurement of the effective antioxidant
ctivity of the compound; a higher TEAC value would imply
reater antioxidant activity of the sample. This assay was cal-
brated with water-soluble -tocophenol analog, Trolox. In
he evaluation of the total antioxidant capacity by ABTS•+
ethod, all the tested compounds were able to quench ABTS•+
adical more efficiently with their TEAC values ranging
etween 12.14 ±  0.34and 42.62 ±  0.25 mmol/L Trolox equiv-
lent/g compound (Table 1). In this context, the compound 6
nd 3 were found to be best and potent scavenging of ABTS•+
adicals, as they were able to quench ABTS•+ radicals more
eadily than the other compound tested. The antioxidant activity
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pig. 1. Chemical structure of isolated compounds 1–6 from Swertia corymbosa
nd ortho-hydroxyl group of compound 3. (C) Metal chelating activity (bindin
011 [51]).
or the compounds observed in the TEAC system is as follows
 > 3  > 4  > 2 > 1  > 5 > BHA. Compound 5 and synthetic antioxi-
ant standard BHA recorded the least activity among the sample
nvestigated.
.2.3. Hydroxyl  radical  scavenging  activity
Hydroxyl radical is one of the most potent oxidants among
he reactive oxygen species and is considered to be the initiator
f lipid peroxidation. It induces several damage to the adja-
ent molecules and can be generated in biological cell through
he Fenton reaction. The scavenging activity was dependent
n the concentration. The same effects of the compound were
3
m
fHMBC and HH connectivity of the isolated compounds. (B) Hydroxyl groups
 of compound 3) (proposal based on Pietta, 2000 [50] and Prochazkova et al.,
bserved in DPPH and ABTS scavenging activities. The IC50
alves were calculated for compound 6 (12.13 ±  2.76 mol/mL)
nd compound 3  (25.13 ±  3.66 mol/mL) revealed effective
H radical quenching capacity. Interestingly, these values were
ignificantly lower (P  < 0.05) than the standard antioxidants
ested (Table 1) indicating their superior radical scavenging
otential..2.4. Nitric  oxide  radical  scavenging  activity
Nitric oxide (NO) is one of the most widespread signaling
olecules and participates virtually in every cellular and organ
unction of the body. It is also a free radical with a single
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npaired electron. The plant products may have the property
o counteract the effect of NO formation and considerable inter-
st in preventing the ill effects of excessive NO generation in
he human body. In the present study, antioxidant abilities of the
solated compounds 1–6  to scavenge. Nitric oxide radical gen-
rated under in  vitro  by sodium nitropursside was investigated.
he calculated IC50 valve obtained from the plots of concentra-
ion dependent inhibition of NO are presented in Table 1. All the
ompounds used for the present study inhibited NO generation
n a concentration dependent manner. The compounds registered
xcellent to moderate antioxidant activity with their IC50 ran-
ing between 18.45 ±  1.23 and 196.45 ±  4.76 M respectively.
he highest measurable activity was found in the compound 6
18.45 ±  1.23 mol/mL) compound 3(23.49 ±  1.29 mol/mL)
nd compound 2  (35.19 ±  2.61 mol/mL).
.2.5.  Superoxide  radical  scavenging  activity
The superoxide radical scavenging activity of compounds
1–6) is presented in Table 1. The ability of the compound
o scavenge superoxide radicals generated in riboflavin-NBT-
ight system in  vitro  was assessed and IC50 under experimental
ondition was calculated. The scavenging ability of the com-
ounds increased with increasing concentration. Compound 6
57.89 ±  3.45 mol/mL) showed maximum scavenging ability
ollowed by compound 3  (87.99 ± 5.61 mol/mL). The IC50
f the standard antioxidant BHA (32.74 ±  2.15 mol/mL) and
HT (27.23 ±  1.76 mol/mL) were remarkably higher than the
ompound 6.
.2.6.  Metal  chelating  activity
The transition metal, iron is capable of generating free
adicals from produced by Fenton reactions. An important mech-
nism of antioxidants activity is the ability to chelate and
eactivate the transition metals. The ability of various com-
ounds isolated from S.  corymbosa  to chelate metal iron (II)
as investigated. Chelating activity against Fe2+ is expressed as
g EDTA equivalent per gram of compound. It can be seen
rom the data presented in Table 1, that all the compounds
ere capable of chelating metal iron. Among the different com-
ounds evaluated, compound 6  exhibited higher chelating ability
213.85 ±  27.18 mg EDTA equivalent per gram of compound).
he metal iron scavenging effect of various compound were in
he order of 6  > 3  > BHA > 4 > 2 > 5 > 1.
.2.7. Ferric  reducing  antioxidant  power  (FRAP)  assay
The FRAP assay measures the ability of antioxidants
o reduce the ferric 2,4,6-tripyridyl-S-triazine complex [Fe
III)-(TPTZ)2]2+ to intensely blue colored ferrous complex
Fe(II)-(TPTZ)2]2+ in acidic medium. FRAP complex and
he results are expressed as concentration of substance hav-
ng ferric-TPTZ reducing ability equivalent to that of 1 mol/L
oncentration of Fe (II). The reduction capacity of a com-
ound may serve as a significant indicator of its potential
ntioxidant activity. The FRAP values for different compounds
re depicted in Table 1. The compounds in general exhib-
ted higher antioxidant capacities and the values ranged from
.13 ±  0.23 to 14.76 ±  0.10 molar Fe(II)/g. Among the samples
1  and Human Wellness 4 (2015) 169–179
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xperimented, compound 6  (14.762 ±  0.10 molar Fe (II)/g)
egistered much higher reducing ability comparable to that
f the positive controls like BHT and BHA. All the com-
ounds showed reducing power but not at the same level. The
rder of FRAP activity of various compound is as follows:
 > 3  > BHA > 4  > 2  > 5 > 1  > BHT.
.2.8. Lipid  proxidation
Malondialdehyde, a secondary product of the oxidation
f polyunsaturated fatty acids, reacts with two molecules of
BA, yielding a pinkish red chromogen with an absorbance
aximum at 532 nm. Isolated compounds inhibited lipid
eroxidation induced by ferrous sulphate in egg yolk
omogenate. IC50 value of lipid peroxidation inhibition was
ecorded in the range of 19.21 ±  3.45–78.59 ±  4.67 mol/mL.
mong the isolated compounds (1–6) examined, the
ompound 6  (19.21 ±  3.45 mol/mL) and compound 3
31.21 ±  4.61 mol/mL) possessed effective inhibiting capac-
ty with the IC50 value less than 32 mol/mL. Interestingly,
hese values were significantly lower (P  < 0.05) that the standard
ntioxidants tested (Table 1) indicating their superior inhibition
otential.
.3.  Anti-proliferative  effect  of  compounds  1–6
The compounds isolated from S.  corymbosa  were evaluated
or the cytotoxic effect on HeLa (human cervical cancer cell line)
epG2 cells (Liver-Human hepatocellular carcinoma) NIH3T3
nd Neuroblastoma (IMR32) cell lines using MTT assay. Cell
ines were cultured with test compound at concentration in the
ange of 6.25, 12.5, 25.00, 50 and 100 mol/mL for 72 h. The
nhibitory effects of these compounds on cell growth was deter-
ined and their IC50 values were arrived (Table 2). When tested
t different concentrations, all the compounds induced a dose
ependent inhibition on cell growth.
In MTT assay, the compound 6  showed chemopreventive
roperties. It strongly and specifically inhibited the prolifera-
ion of HeLa, HepG2 and Neuroblastoma cell lines with the
C50 values of 7.3, 12.46 and 34.67 mol/mL respectively. Fur-
hermore, compound 3  was able to suppress proliferation of
eLa and HepG2 cell lines more effectively than Neuroblastoma
ell with their IC50 values of 13.35, 25.56 and 41.56 mol/mL
espectively. The IC50 values of standard Camptothecin which
nhibited the proliferation of HeLa, HepG2, Neuroblastoma and
IH3T3 cell lines were 5.76, 6.24 and 6.56 and 10.43 mol/mL
espectively and were remarkably higher than the tested com-
ounds.
.4.  In  vitro  anti-inﬂammatory  activity
In the present investigation, the in  vitro  anti-inflammatory
ffect of isolated compound 1–6  was evaluated against denatur-
tion of egg albumin and membrane stabilization. The results
re shown in Fig. 2. Among the compounds tested, compound
 showed significant activity when compared to the standard
iclofenac sodium. IC50 of protein denaturation by compound
 was 10.45 mol/mL.
i
a
t
eig. 2. In vitro anti-inflammatory activity of isolated compounds 1–6. Values
re mean of three replicate determinations (n = 3) mean ± standard deviation.
.5.  Antimicrobial  assay
.5.1.  Disc  diffusion  method
The antimicrobial potential of these compounds (1–6) were
valuvated by measuring the diameter of the zone of inhibition
gainst the pathogens. The results obtained in mm were com-
ared with the standard Ciprofloxacin. The results showed that
ll the isolated compounds were capable of exhibiting antimicro-
ial activity. Among all these compounds, compounds 6 showed
he maximum antimicrobial activity followed by compound 3.
he mean zone of inhibition of the isolated compounds for the
ested microorganisms is tabulated in Table 3.
.5.2. Antimicrobial  activity  (MIC)
The MIC value of the isolated compounds 1–6  is tabulated
n Table 4.
.  Discussion
Free radical damage can be considered as one of the major
ausative factors involved in many diseases such as inflamma-
ion and dementia. It is well established that anti-oxidants are
apable of preventing injury to blood vessel membranes, thereby
ptimizing blood flow to the heart and brain, defending against
ancer-causing DNA damage and thus help lowering the risk
f cancer, cardiovascular and various mental illnesses includ-
ng Alzheimer’s diseases [31,32]. Xanthones are closely related
o the polyphenol family. Therefore, screening natural antioxi-
ants from xanthones should be an effective pathway to discover
ead compounds. In the present study, antioxidant capacity of
ll the isolated xanthones (1–6) was evaluated using the radi-
al DPPH•, ABTS•+, O2•−, OH•, NO, FRAP, metal chelating
ctivity and the inhibition of lipid peroxidation assay. IC50 and
quivalents (TE) per microliter of sample (mmol/L TE) was
sed for the evaluation of the activity. Of these tested com-
ounds, compound 6  exhibited very strong antioxidant activity
n a structural-dependent manner (Table 1). The second most
ctive compound is 3. The great radical scavenging activity of
his compound is quite self-evident that it has a catechol moi-
ty. Compound 6 is a dioxygenated xanthone with two free
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Table 2
Anti-proliferative activity of isolated compound 1–6.
Compounds HeLa IC50 (mol/L) HepG2 IC50 (mol/L) Neuroblastoma IC50 (mol/L) NIH3T3 IC50 (mol/L)
1 50.15 ± 2.34f 45.87 ± 2.27e 53.67 ± 2.38d 41.21 ± 1.21d
2 34.67 ± 0.34d 50.90 ± 2.23f 56.21 ± 1.20d 66.49 ± 0.87e
3 13.35 ± 1.70b 25.56 ± 1.09c 41.56 ± 2.01c 35.51 ± 1.33c
4 27.45 ± 1.23c 39.02 ± 2.21d 42.16 ± 3.56c 41.82 ± 2.17d
5 49.56 ± 0.17e 51.98 ± 1.30f 58.90 ± 1.29d 73.67 ± 1.09f
6 7.3 ± 0.67a 12.46 ± 1.55b 34.67 ± 2.12b 21.67 ± 2.12b
Camptothecin 5.76 ± 1.00a 6.24 ± 1.23a 6.56 ± 0.32a 10.43 ± 1.43a
Values are mean of three replicate determinations (n = 3) ± standard deviation. Mean values followed by different superscripts in a column are significantly different
(P < 0.05).
Table 3
Antimicrobial activity of the isolated compounds from aerial parts of Swertia corymbosa using agar disc diffusion method (zone of inhibition in mm) (25 g/disc).
Micro-organisms Inhibition zone diameters of the test compounds (mm)
1 2 3 4 5 6 Ciprofloxacin
E. coli (ATCC 25922) 10.27 ± 0.11 8.97 ± 0.23 13.47 ± 0.05 9.87 ± 0.05 7.07 ± 0.11 20.27 ± 0.11 21.77 ± 0.11
P. aeruginosa (ATCC 27853) 5.97 ± 0.19 6.17 ± 0.05 11.97 ± 0.05 10.07 ± 0.05 6.17 ± 0.05 15.97 ± 0.11 20.47 ± 0.17
S. aureus (ATCC 29213) 10.17 ± 0.25 8.97 ± 0.23 13.57 ± 0.11 9.67 ± 0.11 2.87 ± 0.11 17.37 ± 0.17 20.77 ± 0.11
S. pneumoniae (ATCC 33400) 4.97 ± 0.23 7.37 ± 0.05 15.27 ± 0.11 11.37 ± 0.11 4.47 ± 0.05 21.21 ± 0.25 21.07 ± 0.05
K. pneumoniae (ATCC 10031) 9.37 ± 0.78 8.87 ± 0.17 13.77 ± 0.05 11.97 ± 0.19 6.87 ± 0.11 15.77 ± 0.11 19.17 ± 0.11
B. subtilis (ATCC 6633) 10.17 ± 0.23 9.97 ± 0.11 15.47 ± 0.05 10.27 ± 0.05 7.97 ± 0.23 17.27 ± 0.17 22.67 ± 0.11
Values are mean ± standard deviation of three experiments in replicate. Ciprofloxacin standard antibacterial agent. 1-Hydroxy-3,7,8-trimethoxyxanthone
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t1), 1,7-dihydroxy-3,8-dimethoxyxanthone(2), 1,2,8-trihydroxy-6 methoxy
etramethoxyxanthone (5) and 1,2-dihydroxy-6-methoxyxanthone-8-O--d-xyl
ydroxyls located at C-1 and C-2, and C-diglycoside at C-8;
hile compound 3  is also a trioxygenated xanthone with three
ree hydroxyls located at C-1, C-2 and C-8.
Generally, xanthones with higher oxygenation display better
ctivity than those with less oxygenation. Glycosylated xan-
hones (6) is more active than those that are not (1–5). 6 is more
ctive than 3 and 2 is more active than 5. Antioxidant capacity of
anthones does not benefit from free hydroxyl group(s) located
nly at either C-1 or C-8 alone. Interestingly, 6  and 3  of the iso-
ated compounds showed highest radical scavenging activities,
hich can be explained by the present of ortho-dihydroxy groups
n their molecular structure [33–35]. The present study revealed
hat the hydroxyl group has strongest influence antioxidant activ-
ties, while methoxyl group has a weak influence (Fig. 1B
nd C).
Cancer diseases are one of the main causes of death world-
ide. The discovery of new molecules from natural origin is a
c
p
a
able 4
ntimicrobial activity (MIC values g/mL) of isolated compounds from aerial parts 
icro-organisms Minimum inhibitory concentration (MIC, g
1 2 3 4
. coli (ATCC 25922) 250 62.5 7.81 1
. aeruginosa (ATCC 27853) 62.5 15.62 3.90 3
. aureus (ATCC 29213) 500 62.5 31.25 1
. pneumoniae (ATCC 33400) 125 31.25 7.81 6
. pneumoniae (ATCC 10031) 125 15.62 15.62 3
. subtilis (ATCC 6633) 125 31.25 3.90 1
alues are mean of three experiments in replicate. Ciprofloxacin and Strept
1), 1,7-dihydroxy-3,8-dimethoxyxanthone(2), 1,2,8-trihydroxy-6 methoxy xan
etramethoxyxanthone (5) and 1,2-dihydroxy-6-methoxyxanthone-8-O--d-xylopyrathone (3), 1,8-dihydroxy-2,6-dimethoxyxanthone (4), 8-hydroxy-1,2,4,6-
nosyl (6).
lobal trending currently for the less toxicity of natural products
36]. The anticancer properties of aerial parts methanol extract
f S.  corymbosa  on HeLa (human cervical cancer), HepG2 cells
Liver-Human hepatocellular carcinoma) and Neuroblastoma
IMR32) cell lines have already been reported by Mahendran
nd Narmatha Bai [7]. MTT assay is most widely used to deter-
ine the cytotoxic potential of medicinal agents and other toxic
aterials. The reduction of yellow MTT to purple colored form-
zan takes place only when mitochondrial reductase enzymes
re active and therefore the conversion can be directly related to
umber of viable cells. The cytotoxic effect of xanthone com-
ounds after 48 h of treatment in HeLa, HepG2, IMR32 and NIH
T3 cells was observed.
The results are presented in Table 2. Among these
ompounds, 1,2-dihydroxy-6-methoxyxanthone-8-O--d-xylo-
yranosyl (6) was found to have significant anti-proliferative
ctivity. The presence of ortho-dihydroxy groups as well as
of Swertia corymbosa.
/mL)
 5 6 Ciprofloxacin Streptomycin
5.62 500 3.90 3.90 1.90
1.25 125 7.81 1.90 3.90
5.62 125 15.62 7.81 1.90
2.5 62.5 3.90 3.90 3.90
1.25 500 1.90 1.90 3.90
5.62 125 7.81 3.90 7.81
omycin standard antibacterial agent. 1-Hydroxy-3,7,8-trimethoxyxanthone
thone (3), 1,8-dihydroxy-2,6-dimethoxyxanthone (4), 8-hydroxy-1,2,4,6-
nosyl (6).
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ydroxyl groups in their basic skeleton of xnathones is respon-
ible of their wide range of activities [37,38]. It was shown that
heir cytotoxic activity could increase with the number and posi-
ion of these groups in their structure [39,40]. This can explain
o a certain degree the interesting antiproliferative activity of the
rtho-dihydroxy groups (3, 6) (Fig. 1b) and non ortho-dihydroxy
roup (1, 2, 4 and 5) reported in the present work. Different
esponses of xanthones by different cell lines have also been
eported by Matsumoto et al. [41] who found that -mangostin
nduced caspase-independent apoptosis via  the mitochondrial
athway in colon cancer cells. In addition, gaudichaudione A, a
ytotoxic xanthone, induced mitochondrial destabilization [42].
herefore, although xanthones induced apoptosis via  different
athways in different cancer cell types, in the present study, sup-
ort that xanthones preferentially target the mitochondria for
poptosis induction.
The antibacterial screening data in Table 3 and 4 shown that
,2-dihydroxy-6-methoxyxanthone-8-O--D-xylopyranosyl
6), 21.21 ±  0.25 and 20.27 ±  0.11 mm zone of inhibition at
5 g/mL concentration tested against S.  pneumoniae  and
. coli  with MIC of 3.90–15.62 g/mL against most of the
ested bacteria. Compared to it, the three compounds 1, 2
nd 5  are less active (MIC < 500 g/mL), showing that the
ydroxyl function and ortho-dihydroxy are important for its
ntimicrobial activity. The reduced activity of 1, 2  and 5 is
n agreement with the results of Dharmaratne et al. [43] who
ound that increasing the methoxy groups in xanthone skeleton
heir antimicrobial activity reduced drastically. The increased
ctivity of the isolated compounds (6) can be explained by
he electron delocalization over the whole molecules. This
elocalization increases the lipophilic character of the molecule
6) and favors their permeation through the lipoid layer of
acterial membranes. The increased lipophilic character of the
olecule seems to be responsible for their enhanced antibac-
erial activities [44]. It has been suggested that this molecule
eactivate various cellular enzymes that play vital roles in
he various metabolic pathways of these microorganisms.
he activity of molecules 3  and 6  were tested against some
uman pathogenic bacteria, including Gram-positive bacteria
S. aureus  and S.  pneumoniae) and Gram-negative bacteria
E. coli, P.  aeruginosa,  K.  pneumonia  and B.  subtilis) using
he paper disc method (Table 3) and minimum inhibitory con-
entration (Table 4). The results obtained using these methods
emonstrate that the tested molecules were highly active even
t low concentrations. The results of the antibacterial screening
ndicate that compound 6  inhibits the growth of S.  pneumoniae,
. coli  and K.  pneumoniae, but this compound is less active
gainst the other tested bacteria.
In the present investigation, the in  vitro-anti-inflammatory
ffect of isolated compound 1–6  was evaluated against dena-
uration of egg albumin and membrane stabilization. Among
he compounds tested, compound 6 showed significant activ-
ty when compared to the standard diclofenac sodium. The
roduction of auto antigens in inflammatory diseases may be
ue to in vivo  denaturation of protein. The mechanism of dena-
uration possibly involves alteration in electrostatic, hydrogen,
ydrophobic and disulphide bonding [45]. From the result, ituman Wellness 4 (2015) 169–179
an be stated that the compound 6  was capable of controlling
he production of auto antigen and thereby it inhibit the denatur-
tion of proteins and its effect was compared with the standard
rug diclofenac sodium.
The isolated compound 6 exhibited membrane stabilization
ffect by inhibiting hypotonicity induced lysis of GRBC. The
rythrocyte membrane is analogous to the liposomal membrane
46,47] and its stabilization implies that the compound may as
ell stabilize lysosomal membranes. Stabilization of lysosomal
embrane is important in limiting the inflammatory response
y preventing the release of lysosomal constituents of acti-
ated neutrophil such as bactericidal enzymes and proteases
hich cause further tissue inflammation and damage upon extra
ellular release [48]. Though the exact mechanism of the mem-
rane stabilization by the test compound is not known yet;
ypotonicity-induced hemolysis may arise from shrinkage of
he cells due to osmotic loss of intracellular electrolyte and fluid
omponents or interaction with membrane proteins [27,49]. The
ompound may inhibit the processes, which may stimulate or
nhance the efflux of these intracellular components. On the
asis of the above results it can be concluded that the isolated
ompounds had anti inflammatory activity.
.  Conclusion
In the present investigation, we have evaluated the antiox-
dant, anti-microbial, anti-proliferative and anti-inflammatory
ffect of xanthones isolated from S.  corymbosa. Based on pre-
iminary anti-proliferative activity, the active constituents 3  and
 showed anti-proliferative effect via  mitochondrial-mediated
poptosis induction by cell cycle arrest. Similarly, antiradi-
al, anti-inflammatory and antibacterial activities were also
erformed and showed significant activity. Further studies are
urrently underway to assess the in  vivo  biological activities and
o identify the molecular mechanism behind these biological
ctivities.
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